JULY 30, 2020- COLLEGE STATION, TEXAS – Solenic Medical, a developer of a device that uses alternating magnetic fields to treat a prosthetic joint infections (PJI) announced today that it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). >>Full Article
Solenic Medical, Inc. Receives FDA Breakthrough Device Designation for AMF Device
Bookmark the permalink.